×
About 38,263 results

Expert shares top five atopic dermatitis–related questions he fields
https://www.mdedge.com/dermatology/article/249375/atopic-dermatitis/expert-shares-top-five-atopic-dermatitis-related
Doug Brunk

Dec 2nd, 2021 - Will my child outgrow the eczema? That is perhaps the No. 1 atopic dermatitis–related question that Lawrence F.

HPV vaccines reduce cervical cancer rates in young females
https://www.mdedge.com/obgyn/article/249343/gynecologic-cancer/hpv-vaccines-reduce-cervical-cancer-rates-young-females
Pam Harrison

Dec 1st, 2021 - Two different studies have found that, provided young females are immunized with the human papilloma virus (HPV) vaccine at a young enough age, both the incidence of and mortality from cervical cancer can be dramatically curtailed, data from the United Kingdom and to a lesser extent, the United States indicate. In the U.

ANKRD36: A novel biomarker of CML disease progression
https://www.mdedge.com/hematology-oncology/article/249278/cml/ankrd36-novel-biomarker-cml-disease-progression

Dec 1st, 2021 - Key clinical point: Mutations in a novel gene ANKRD36 were associated with disease progression in chronic myeloid leukemia (CML) and may help identify patients at risk of disease progression. Major finding: Mutations in the ANKRD36 gene (c.

UPDATE 1-Telefonica offers redundancy to 3,000-plus staff, union says
https://www.reuters.com/article/telefonica-layoffs/update-1-telefonica-offers-redundancy-to-3000-plus-staff-union-says-idUSL1N2SL1QK

Nov 30th, 2021 - (Adds detail, quote, context) MADRID, Nov 30 (Reuters) - Telefonica will offer voluntary redundancy to staff born in 1967 or earlier and with at least 15 years of employment at the company, the UGT union said on Tuesday, calculating that 3,261 employees would meet those conditions. Europe’s third-largest telecoms group and direct employer of 16,000 people in Spain would limit take-up of the off...

Facebook says it disagrees with UK ruling on Giphy deal
https://www.reuters.com/article/giphy-ma-meta-platforms-response/facebook-says-it-disagrees-with-uk-ruling-on-giphy-deal-idUSL9N2Q500B

Nov 30th, 2021 - LONDON, Nov 30 (Reuters) - Facebook-owner Meta said on Tuesday it disagreed with the British competition regulator’s ruling that it must sell animated images platform Giphy. “We disagree with this decision,” A Meta spokesperson said. “We are reviewing the decision and considering all options, including appeal.” (Reporting by Paul Sandle; Editing by Alistair Smout)

Britain regulator directs Facebook to sell GIF maker Giphy
https://www.reuters.com/article/giphy-ma-meta-platforms-britain/britain-regulator-directs-facebook-to-sell-gif-maker-giphy-idUSL4N2SL2QB

Nov 30th, 2021 - Nov 30 (Reuters) - Britain’s competition regulator said on Tuesday it has directed Facebook owner Meta Platforms to sell animated images platform Giphy, after finding that the deal could harm social media users and UK advertisers. (Reporting by Yadarisa Shabong and Pushkala Aripaka in Bengaluru; Editing by Shounak Dasgupta)

National Grid, Scottish Power to pay $211 mln to customers after Western Link probe
https://www.reuters.com/article/ntnl-grid-elec-ofgem/national-grid-scottish-power-to-pay-211-mln-to-customers-after-western-link-probe-idUSL4N2SL2OS

Nov 30th, 2021 - Nov 30 (Reuters) - Electricity companies National Grid Electricity Transmission and Scottish Power Transmission have agreed to pay 158 million pounds ($211.12 million) to customers and British energy regulator Ofgem for a two-year delay to Western Link project. Ofgem said the companies have acknowledge the project, an undersea electrical link in the UK, was delivered later that scheduled. The r...

FTSE 100 eyes worst month in more than a year on Omicron hit
https://www.reuters.com/article/britain-stocks/ftse-100-eyes-worst-month-in-more-than-a-year-on-omicron-hit-idUSL4N2SL21D

Nov 30th, 2021 - (For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * FTSE 100 down 0.9%, FTSE 250 off 0.7% Nov 30 (Reuters) - UK’s blue-chip index fell on Tuesday, on course for its worst month in more than a year, as a warning by Moderna’s chief executive over the new Omicron coronavirus variant hammered pandemic-exposed sectors like banks and commodit...

BRIEF-Astrazeneca Says Lynparza Granted FDA Priority Review For Olympia
https://www.reuters.com/article/brief-astrazeneca-says-lynparza-granted/brief-astrazeneca-says-lynparza-granted-fda-priority-review-for-olympia-idUSASN001XX2

Nov 30th, 2021 - Nov 30 (Reuters) - AstraZeneca PLC: * ASTRAZENECA PLC - LYNPARZA GRANTED FDA PRIORITY REVIEW FOR OLYMPIA * ASTRAZENECA - LYNPARZA GRANTED PRIORITY REVIEW IN US FOR BRCA-MUTATED HER2-NEGATIVE HIGH-RISK EARLY BREAST CANCER Source text for Eikon: Further company coverage:

Pub operator Marston's posts wider loss, withholds dividend
https://www.reuters.com/article/marstons-results/pub-operator-marstons-posts-wider-loss-withholds-dividend-idUSL4N2SL202

Nov 30th, 2021 - Nov 30 (Reuters) - Pub operator Marston’s Plc posted a bigger annual loss on Tuesday and withheld dividend citing potential for continuing uncertainty, as a new variant of the coronavirus identified last week threatens a sustained economic rebound. The company, which has about 1,500 pubs in the UK, still said bookings for the Christmas period was encouraging and in line with pre-pandemic levels...

European stock futures tumble after Moderna CEO raises vaccine efficacy doubts
https://www.reuters.com/article/europe-stocks/european-stock-futures-tumble-after-moderna-ceo-raises-vaccine-efficacy-doubts-idUSL4N2SL1UR

Nov 30th, 2021 - (For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) Nov 30 (Reuters) - European stock index futures fell sharply in early trading on Tuesday, after drugmaker Moderna’s head cast doubts over the efficacy of COVID-19 vaccines against the Omicron coronavirus variant. Euro STOXX 50 futures dropped 1.7% by 0637 GMT, as a bout of risk aversion ...

Visual snow: Alarming and not uncommon
https://www.mdedge.com/neurology/article/249122/headache-migraine/visual-snow-alarming-and-not-uncommon
Jim Kling

Nov 29th, 2021 - ‘Grainy’ or ‘pixelated’ vision can be an alarming symptom for patients. The phenomenon is called visual snow, and although it was first described only recently, it is fairly common.

BRIEF-Google, On Update On Privacy Sandbox Commitments, Says Offered To Appoint Independent Monitoring Trustee - Blog
https://www.reuters.com/article/brief-google-on-update-on-privacy-sandbo/brief-google-on-update-on-privacy-sandbox-commitments-says-offered-to-appoint-independent-monitoring-trustee-blog-idUSFWN2SH08N

Nov 26th, 2021 - Nov 26 (Reuters) - Alphabet Inc: * GOOGLE, ON UPDATE ON PRIVACY SANDBOX COMMITMENTS, SAYS OFFERED TO APPOINT INDEPENDENT MONITORING TRUSTEE - BLOG * GOOGLE - OFFERED CMA MORE EXTENSIVE TESTING COMMITMENTS, ALONG WITH MORE TRANSPARENT PROCESS TO TAKE MARKET FEEDBACK ON THE PRIVACY SANDBOX PROPOSALS * GOOGLE ON PRIVACY SANDBOX-CO NOT TO USE GOOGLE FIRST-PARTY PERSONAL DATA TO TRACK USERS FOR TARG...

Home Infusion Trend Stirs Debate
https://www.onclive.com/view/home-infusion-trend-stirs-debate

Nov 24th, 2021 - The COVID-19 pandemic spurred the launching or expansion of in-home cancer therapy infusion programs at several oncology centers around the United States, drawing a surge of interest throughout the field as well as opposition from oncologists who are concerned about the implications for patient safety and the potential impact on community practices that provide in-house infusion services. In a...

The Use of Nasogastric Tube Bridle Kits in COVID-19 Intensive Care Unit Patients
https://www.mdedge.com/jcomjournal/article/249079/covid-19-updates/use-nasogastric-tube-bridle-kits-covid-19-intensive-care
Rajveer Atkar, MBBS, Bryce Clark, MB, ChB et. al.

Nov 23rd, 2021 - From Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Birmingham, United Kingdom. Objective: To ascertain the extent of nasogastric tube (NGT) dislodgment in COVID-19 intensive care unit (ICU) patients after the introduction of NGT bridle kits as a standard of practice, to see whether this would reduce the number of NGT insertions, patient irradiation, missed feeds, and overall cost.

Enasidenib/Azacitidine Combo Shows Early, Promising Activity in IDH2-Mutant AML
https://www.onclive.com/view/enasidenib-azacitidine-combo-shows-early-promising-activity-in-idh2-mutant-aml

Nov 23rd, 2021 - The combination of enasidenib (Idhifa) plus azacitidine (Onureg) was well tolerated and induced significantly improved response rates compared with azacitidine alone in patients with newly diagnosed, IDH2-mutant acute myeloid leukemia (AML), according to results from the phase 1b/2 AG221-AML-005 trial (NCT02677922) published in Lancet Oncology.1 Results from the study showed that among patient...

European shares tumble on COVID surge, rate hike fears
https://www.reuters.com/article/europe-stocks/european-shares-tumble-on-covid-surge-rate-hike-fears-idUSL4N2SE1KI

Nov 23rd, 2021 - (For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) Nov 23 (Reuters) - European stocks slumped to three-week lows on Tuesday as a resurgence of COVID-19 cases and rate hike concerns knocked sentiment ahead of flash readings on euro zone business activity. The pan-European STOXX 600 dropped 1% by 0815 GMT, after Asian markets followed Wall...

UK government agrees to appoint special administrators for Bulb -PM's spokesman
https://www.reuters.com/article/power-prices-britain-bulb-johnson/uk-government-agrees-to-appoint-special-administrators-for-bulb-pms-spokesman-idUSS8N2R108C

Nov 22nd, 2021 - LONDON, Nov 22 (Reuters) - The British government has agreed with energy regulator Ofgem to appoint special administrators for Bulb, Prime Minister Boris Johnson’s spokesman said on Monday. Bulb has become the biggest UK energy supplier so far to run into trouble since a recent surge in wholesale gas and electricity prices. “We have agreed with Ofgem on the appointment of special administrators...

Guillain-Barré Syndrome Associated with COVID-19 Vaccination
https://wwwnc.cdc.gov/eid/article/27/12/21-1634_article

Nov 21st, 2021 - Guillain-Barré syndrome (GBS), an immune-mediated polyradiculoneuropathy with a ≈5% mortality rate, has an incidence worldwide of 0.81–1.91 cases/100,000 person-years (1). GBS has been reported to be associated with coronavirus disease (COVID-19) vaccination, but a comprehensive summary regarding this rare adverse event is still lacking. To determine clinical features of GBS associated with COV...

Real-Time Projections of SARS-CoV-2 B.1.1.7 Variant in a University Setting, Texas, USA
https://wwwnc.cdc.gov/eid/article/27/12/21-0652_article

Nov 21st, 2021 - Identification of the highly transmissible novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant B.1.1.7 (Alpha variant) in the United Kingdom raised concerns for renewed pandemic surges worldwide (1,2). B.1.1.7 likely arrived in the United States by October 2020 (1); it was first detected in December 2020 and declared the dominant strain in April 2021, as projected in Janu...